clinical trial · NCT00400218
Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)
Organon and Co·phase3·completed·n = 62
HypertensionMK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks
brief summary
Evaluate the safety and anti-hypertensive efficacy of hyzaar(R) in patients with mild to moderate essential hypertension.
started
Sep 1, 2005
primary completion
Jul 1, 2006
completion
Jul 19, 2006
last updated
Aug 15, 2024
official title
Evaluate the Safety and Tolerability of Hyzaar(R) (Losartan 50 Mg/ Hydrochlorothiazide 12.5 Mg) In the Treatment of Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol